Asia-Pacific Smart Pill Technologies Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Smart pills or nootropics are small medical and embedded electronic devices such as sensors, cameras, and trackers which can be quickly swallowed and provides a complete evaluation of the gastrointestinal tract. Smart pills have reduced the difference between digital and healthcare technology. However, real-time patient monitoring is possible with intelligent pills diagnostics and can record bodily functions of the patients.

Asia Pacific Smart Pills Technologies Market Segments Size & Growth:

Asia Pacific Smart Pills Technologies Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are due to the prevalence of Gastro-Intestinal diseases; it reduces invasive surgeries and technological developments in capsule endoscopy. However, lack of skilled professionals, expensive treatment, and ethical issues hinder the growth of the Asia Pacific smart pills diagnostics market.

Asia Pacific Smart Pills Technologies Market Segments Share:

Asia PacificSmart Pills Diagnostics Market is categorised into by test organ which consists of stomach, oesophagus, small intestine, and large intestine. The small and large intestine has the most significant share as it is affected while a gastro-intestinal disorder rises. By application, smart pills diagnostics market is segmented as capsule endoscopy, diagnostic imaging, patient monitoring, and drug delivery. Among all capsule endoscopy are expected to have high growth rate during the forecast period 2018-2024, due to increase in GI tract, and it performs adequately.

By Geography, China is dominating the smart pills diagnostics market, and the growth in the Asia Pacific is mainly attributed because of the increasing non-invasive diagnosis. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, awareness about GI tract and diagnostic methods.

Asia Pacific Smart Pills Technologies Market SegmentsTrends:

• New technological smart pill “Gut microbiome” helps to monitor gastrointestinal tract has been tested in January 2018.
• In March 2017, Boston Scientific Corporationacquired Symetis Corporation to expand treatments for vascular diseases.

Asia Pacific Smart Pills Technologies Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Boston Scientific Corporation
• Medisafe
• Capsovision Inc.
• IntroMedic Co., Ltd.,
• GE Healthcare